Business

Vaccines alliance signs $5 million advance deal for Merck’s Ebola shot

Vaccines alliance signs $5 million advance deal for Merck's Ebola shot

A transmission electron micrograph shows Ebola virus particles in this undated handout image released by the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID) in Fredrick, Maryland. The Gavi global alliance for vaccines and immunization group signed a $5 million advance purchase commitment on Wednesday to buy a vaccine being developed by Merck to protect against future outbreaks of the deadly Ebola virus. Gavi said the agreement would help the U.S. drugmaker take the experimental Ebola vaccine through late-stage clinical trials to licensing and then through pre-qualification by the World Health Organization (WHO). If approved, Merck’s so-called VSV-ZEBOV […]

To Top